Central Nervous System (CNS) Safety Pharmacology Studies-Reference-Cited by-同舟云学术

Central Nervous System (CNS) Safety Pharmacology Studies

Published:2006 Issue: Volume: Page:15-60
ISSN:
Container-title:Drug Discovery and Evaluation
language:
Short-container-title:

Author:

Porsolt Roger D.,Castagné Vincent,Dürmüller Niklaus,Lemaire Martine,Moser Paul,Roux Sylvain,France Charles P.

Publisher

Springer Berlin Heidelberg

Link

http://link.springer.com/content/pdf/10.1007/3-540-29804-5_3.pdf

Reference92 articles.

1. Anon (1995) Japanese Guidelines for Nonclinical Studies of Drugs Manual. Pharmaceutical Affairs Bureau, Japanese Ministry of Health and Welfare, Yakugi Nippo

2. Anon (2000) ICH S7A: Safety Pharmacology studies for human pharmaceuticals. European Agency for the Evaluation of Medicinal Products. Evaluation of Medicines for Human Use. CPMP/ICH/539/00, London, 16 November 2000

3. Aspen JM, Winger G (1997) Ethanol effects on self-administration of alfentanil, cocaine, and nomifensine in rhesus monkeys. Psychopharmacology 130:222–227

4. Ator NA, Griffiths RR (1989) Differential generalization to pentobarbital in rats trained to discriminate lorazepam, chlordiazepoxide, diazepam and triazolam. Psychopharmacology 98:20–30

5. Bals-Kubik R, Ableitner A, Herz A, Shippenberg TS (1993). Neuroanatomical sites mediating the, motivational effects of opioids as mapped by the conditioned place preference paradigm in rats. J Pharmacol Exp Ther 264:489–495

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Motor Function in Rodent Models of Neurodegenerative Disorders;Springer Protocols Handbooks;2013-09-30

2. Current Practices in Safety Pharmacology;Pharmaceutical Sciences Encyclopedia;2010-03-15